E-cigarette regulations should be relaxed to make vaping more attractive to smokers of traditional cigarettes, expert witnesses have told a House of Commons Science and Technology Select Committee hearing. Riccardo Polosa, professor of internal medicine […]
Resverlogix Corporation (“Resverlogix” or the “Company”) (TSX:RVX) and the Resverlogix BETonMACE Clinical Steering Committee (CSC), represented by Professor Kausik Ray (Chair), are pleased to announce the FDA acceptance of the Company’s Phase 3 BETonMACE trial […]
Shares of Diffusion Pharmaceuticals shot up more than 40 percent Tuesday after the company provided an overview of the company and its Phase III candidate used to treat brain cancer patients where tumor hypoxia (oxygen […]
Avadel Pharma (NASDAQ:AVDL), “Avadel” or “the Company,” today announced that FT 218 has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy. FT 218, a once-nightly […]
Delcath Systems (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a modification agreement with the U.S. Food and Drug Administration (FDA) for its […]